353 related articles for article (PubMed ID: 20151980)
1. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
Andrès E; Maloisel F; Zimmer J
Br J Haematol; 2010 Jul; 150(1):3-8. PubMed ID: 20151980
[TBL] [Abstract][Full Text] [Related]
2. Idiosyncratic drug-induced agranulocytosis or acute neutropenia.
Andrès E; Maloisel F
Curr Opin Hematol; 2008 Jan; 15(1):15-21. PubMed ID: 18043241
[TBL] [Abstract][Full Text] [Related]
3. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
Góra-Tybor J; Krykowski E; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166
[TBL] [Abstract][Full Text] [Related]
4. [Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis].
Hospers GA; de Wolf JT; Hazenberg BP; Vellenga E
Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2152-4. PubMed ID: 7694163
[TBL] [Abstract][Full Text] [Related]
5. G-CSF and the management of clozapine-induced agranulocytosis.
Gerson SL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-colony stimulating factor therapy in drug-induced agranulocytosis.
Mani S; Barry M; Concato J
Arch Intern Med; 1993 Nov; 153(21):2500-1. PubMed ID: 7692832
[TBL] [Abstract][Full Text] [Related]
7. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases.
Sprikkelman A; de Wolf JT; Vellenga E
Leukemia; 1994 Dec; 8(12):2031-6. PubMed ID: 7528854
[TBL] [Abstract][Full Text] [Related]
8. [Agranulocytosis induced by synthetic antithyroid drugs: efficacy of hematopoietic growth factors].
Genet P; Pulik M; Lionnet F; Bremont C
Ann Endocrinol (Paris); 1994; 55(1):39-42. PubMed ID: 7528487
[TBL] [Abstract][Full Text] [Related]
9. The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF).
Chengappa KN; Gopalani A; Haught MK; McChesney K; Baker RW; Schooler NR
Psychopharmacol Bull; 1996; 32(1):111-21. PubMed ID: 8927660
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report.
Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW
J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
Hurtado R; Candelaria M; Majluf-Cruz A; Sosa-Camas RE; Labardini-Méndez J
Rev Invest Clin; 1994; 46(1):59-61. PubMed ID: 8079066
[TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
Kuipers EJ; Vellenga E; de Wolf JT; Hazenberg BP
J Rheumatol; 1992 Apr; 19(4):621-2. PubMed ID: 1350640
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients treated with hematopoietic growth factors for idiosyncratic drug-induced agranulocytosis.
Andrès E; Noel E; Maloisel F
Am J Med; 2004 Mar; 116(5):354. PubMed ID: 14984824
[No Abstract] [Full Text] [Related]
15. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
16. Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis.
Ibáñez L; Sabaté M; Ballarín E; Puig R; Vidal X; Laporte JR;
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):224-8. PubMed ID: 18181220
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of methimazole-induced agranulocytosis with granulocyte-macrophage colony stimulating factor].
Somogyi A; Werling K; Rosta A; Láng I
Orv Hetil; 1994 Nov; 135(45):2483-5. PubMed ID: 7991239
[TBL] [Abstract][Full Text] [Related]
18. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and management of drug-induced agranulocytosis.
Andrès E; Zimmer J; Mecili M; Weitten T; Alt M; Maloisel F
Expert Rev Hematol; 2011 Apr; 4(2):143-51. PubMed ID: 21495924
[TBL] [Abstract][Full Text] [Related]
20. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
